Cargando…

An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Sophora flavescens (S. flavescens), also named Kushen, is a famous Chinese herbal medicine that has been used to prevent and cure T2DM both in folk medicine and in medical institution. However, its mechanism of action remains unclear. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Jing, Liu, Yi, Wang, Huan, Luo, Yun, Chen, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273480/
https://www.ncbi.nlm.nih.gov/pubmed/32566075
http://dx.doi.org/10.1155/2020/1805418
_version_ 1783542414349172736
author Shao, Jing
Liu, Yi
Wang, Huan
Luo, Yun
Chen, Lei
author_facet Shao, Jing
Liu, Yi
Wang, Huan
Luo, Yun
Chen, Lei
author_sort Shao, Jing
collection PubMed
description Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Sophora flavescens (S. flavescens), also named Kushen, is a famous Chinese herbal medicine that has been used to prevent and cure T2DM both in folk medicine and in medical institution. However, its mechanism of action remains unclear. In this study, the pharmacodynamic effects of S. flavescens EtOAc extract (SFE) on high-fat diet and low-dose streptozotocin-induced T2DM rats were examined. Fecal metabolomics analysis and 16S rRNA gene sequencing were applied to determine the influence of T2DM and SFE treatment on gut microbiota and host metabolism. Based on the consistency of the results of metabolic pathways in metabolomics analysis and phylogenetic investigation of communities by reconstruction of unobserved state (PICRUSt) analysis of 16S rRNA gene sequencing, the level of metabolites and the operational taxonomic units of gut bacteria were combined, and Spearman's analysis was implemented. Our data showed that SFE significantly decreased fasted blood glucose levels and improved lipid profile, glycosylated serum protein, glycosylated hemoglobin index, and pancreas damage. Metabolomics and 16S rRNA gene sequencing analysis indicated gut bacteria disorder, disturbed lipid metabolism, carbohydrate metabolism, and especially amino acid metabolism in T2DM and that SFE can regulated these metabolic pathways through the influence on gut bacteria. Spearman's analysis indicated that the amino acid metabolism that included tryptophan, branched chain amino acid, aromatic amino acid, beta-alanine, and glycine, serine and threonine metabolism, lipid metabolism, including lysophosphatidylcholines and lysophosphatidylethanolamines, primary bile acid and linoleic acid metabolism, carbohydrate metabolism, and nucleotide metabolism positively correlated with Faecalibacterium, Flexispira, Phascolarctobacterium, Prevotella, Roseburia, and [Prevotella]. In addition, arginine and proline metabolism, steroid hormone, steroid biosynthesis, and sphingolipid metabolism positively correlated with Lactobacillus, Oscillospira, Parabacteroides, Ruminococcus, and Streptococcus. Taken together, we speculated that SFE may have an effect on T2DM by mediating host-microbial metabolic axis. Exploration of SFE treatment for T2DM by multiomics is expected to provide a reference for clinical treatment.
format Online
Article
Text
id pubmed-7273480
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72734802020-06-19 An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens Shao, Jing Liu, Yi Wang, Huan Luo, Yun Chen, Lei Oxid Med Cell Longev Research Article Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease. Sophora flavescens (S. flavescens), also named Kushen, is a famous Chinese herbal medicine that has been used to prevent and cure T2DM both in folk medicine and in medical institution. However, its mechanism of action remains unclear. In this study, the pharmacodynamic effects of S. flavescens EtOAc extract (SFE) on high-fat diet and low-dose streptozotocin-induced T2DM rats were examined. Fecal metabolomics analysis and 16S rRNA gene sequencing were applied to determine the influence of T2DM and SFE treatment on gut microbiota and host metabolism. Based on the consistency of the results of metabolic pathways in metabolomics analysis and phylogenetic investigation of communities by reconstruction of unobserved state (PICRUSt) analysis of 16S rRNA gene sequencing, the level of metabolites and the operational taxonomic units of gut bacteria were combined, and Spearman's analysis was implemented. Our data showed that SFE significantly decreased fasted blood glucose levels and improved lipid profile, glycosylated serum protein, glycosylated hemoglobin index, and pancreas damage. Metabolomics and 16S rRNA gene sequencing analysis indicated gut bacteria disorder, disturbed lipid metabolism, carbohydrate metabolism, and especially amino acid metabolism in T2DM and that SFE can regulated these metabolic pathways through the influence on gut bacteria. Spearman's analysis indicated that the amino acid metabolism that included tryptophan, branched chain amino acid, aromatic amino acid, beta-alanine, and glycine, serine and threonine metabolism, lipid metabolism, including lysophosphatidylcholines and lysophosphatidylethanolamines, primary bile acid and linoleic acid metabolism, carbohydrate metabolism, and nucleotide metabolism positively correlated with Faecalibacterium, Flexispira, Phascolarctobacterium, Prevotella, Roseburia, and [Prevotella]. In addition, arginine and proline metabolism, steroid hormone, steroid biosynthesis, and sphingolipid metabolism positively correlated with Lactobacillus, Oscillospira, Parabacteroides, Ruminococcus, and Streptococcus. Taken together, we speculated that SFE may have an effect on T2DM by mediating host-microbial metabolic axis. Exploration of SFE treatment for T2DM by multiomics is expected to provide a reference for clinical treatment. Hindawi 2020-05-27 /pmc/articles/PMC7273480/ /pubmed/32566075 http://dx.doi.org/10.1155/2020/1805418 Text en Copyright © 2020 Jing Shao et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Shao, Jing
Liu, Yi
Wang, Huan
Luo, Yun
Chen, Lei
An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens
title An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens
title_full An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens
title_fullStr An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens
title_full_unstemmed An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens
title_short An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from Sophora flavescens
title_sort integrated fecal microbiome and metabolomics in t2dm rats reveal antidiabetes effects from host-microbial metabolic axis of etoac extract from sophora flavescens
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273480/
https://www.ncbi.nlm.nih.gov/pubmed/32566075
http://dx.doi.org/10.1155/2020/1805418
work_keys_str_mv AT shaojing anintegratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT liuyi anintegratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT wanghuan anintegratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT luoyun anintegratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT chenlei anintegratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT shaojing integratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT liuyi integratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT wanghuan integratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT luoyun integratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens
AT chenlei integratedfecalmicrobiomeandmetabolomicsint2dmratsrevealantidiabeteseffectsfromhostmicrobialmetabolicaxisofetoacextractfromsophoraflavescens